Baseline Characteristics | No Treatment (N = 102) | PDT (N = 138) | Bevacizumab (N = 130) | Ranibizumab (N = 103) | P-value |
---|---|---|---|---|---|
Female (%) | 51 (50) | 79 (57) | 77 (59) | 54 (52) | 0.5 |
Mean age ± SD | 77.7 ± 7.8 | 76.9 ± 7.5 | 78.6 ± 6.9 | 80.8 ± 6.3 | < 0.0001 |
Angiographic lesion subtypea |  |  |  |  | < 0.0001 |
 Predominantly classic (%) | 40 (39) | 82 (59) | 33 (25) | 49 (48) |  |
 Minimally classic (%) | 11 (11) | 16 (12) | 24 (19) | 10 (10) |  |
 Occult with no classic (%) | 46 (45) | 36 (26) | 59 (45) | 36 (35) |  |
 Cannot classify: obscuring lesion (%) | 5 (5) | 4 (3) | 14 (11) | 6 (6) |  |
 Cannot classify: photo quality (%) | – | – | – | 2 (2) |  |
Angiographic non-CNV components of lesiona | Â | Â | Â | Â | Â |
 Elevated blocked hypofluorescence | 1 (1) | 2 (1) | 1 (1) | – | 0.7 |
 Blood | 36 (35) | 74 (54) | 58 (45) | 54 (52) | 0.02 |
 PED | 6 (6) | 8 (6) | 15 (12) | 6 (6) | 0.2 |
 Fibrous tissue | – | – | 1 (1) | – | 0.5 |
Angiographic measurements | Â | Â | Â | Â | Â |
 Size CNV (disc diameters) ± SD | 1.3 ± 0.8 | 1.4 ± 0.8 | 1.2 ± 0.8 | 1.2 ± 0.7 | 0.3 |
 Missing size CNV | 2 | 1 | – | – |  |
 Size of lesion (disc diameters) ± SD | 1.8 ± 0.8 | 1.8 ± 0.8 | 2.0 ± 0.8 | 1.9 ± 0.8 | 0.3 |
Angiographic classification of fellow eyeb |  |  |  |  | < 0.0001 |
 No nAMD (%) | 11 (11) | 22 (16) | 26 (20) | 23 (22) |  |
 Early or intermediate nAMD (%) | 40 (39) | 41 (30) | 51 (39) | 30 (29) |  |
 Advanced nAMD (%) | 49 (48) | 64 (46) | 51 (39) | 35 (34) |  |
 Cannot classify: photo quality (%) | 2 (2) | 11 (8) | 2 (2) | 15 (15) |  |
Visual acuity | Â | Â | Â | Â | Â |
 Study eye LogMAR ± SD | 0.82 ± 0.49 | 0.73 ± 0.37 | 0.73 ± 0.41 | 0.77 ± 0.48 | 0.3 |
 Fellow eye LogMAR ± SD | 0.67 ± 0.73 | 0.64 ± 0.75 | 0.70 ± 0.82 | 0.64 ± 0.76 | 0.9 |
 Best eye LogMAR ± SD | 0.38 ± 0.33 | 0.36 ± 0.35 | 0.35 ± 0.32 | 0.38 ± 0.40 | 0.9 |